I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
The bit I cannot resolve on my own is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Numbers rather than impressions, if you have them.
Taking the question as asked, rather than the general version of it. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.
Ask again with the specifics and you will get a better answer than this one.
CarlaRPh_TPA said:If two explanations both fit, the useful question is which one predicts something the other does not.
That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsRegAffairsDC said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Can confirm. Same sequence, different timescale. Posting only so the count is not one.
Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.